Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Hormone therapy could reduce nocturnal urge to urinate

Written by | 12 Apr 2021

Article written by Bruce Sylvester. Hormone therapy appears to reduce thenumber of times nightly that postmenopausal women wake up from sleep with the need to urinate.

Soft “sweat stickers” may streamline diagnosis of cystic fibrosis in children

Written by | 11 Apr 2021

New “sweat stickers” may streamline the early diagnosis of cystic fibrosis by enabling scientists to easily gather and analyze sweat from the skin of infants and children. The… read more.

Novel pharmacological strategies to treat alcoholism. Focus on epigenetics

Written by | 11 Apr 2021

Abusive alcohol drinking considerably impacts human health. Alcoholism, better defined as Alcohol Use Disorders (AUD), includes a group of pathological entities related to alcohol-induced damage. Individuals with AUD… read more.

FDA approves Qelbree for attention-deficit hyperactivity disorder in pediatric patients – Supernus Pharmaceuticals

Written by | 10 Apr 2021

Supernus Pharmaceuticals announced that the FDA approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age…. read more.

Latest CT chest findings in marijuana smokers

Written by | 10 Apr 2021

A Scientific E-Poster to be presented at the 2021 ARRS Virtual Annual Meeting reveals increased rates of emphysema in marijuana smokers, compared to both non-smokers and tobacco-only smokers,… read more.

AZD 1222 US phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis – AstraZeneca

Written by | 9 Apr 2021

The AstraZeneca US Phase III trial of AZD 1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy at preventing severe disease and… read more.

Screen time for older adults: Mobile health tech can support seniors with heart disease

Written by | 9 Apr 2021

DALLAS, April 1, 2021 — Mobile health technology can be beneficial in encouraging lifestyle behavior changes and medication adherence among adults ages 60 and older with existing heart… read more.

FDA approves Zegalogue for severe hypoglycemia in pediatric and adult patients with diabetes – Zealand Pharma

Written by | 8 Apr 2021

Zealand Pharma announced that the FDA has approved Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and… read more.

Exposure to harmful chemicals in plastic may contribute to postpartum depression

Written by | 8 Apr 2021

Endocrine-disrupting chemicals may influence hormonal shifts during pregnancy as well as contribute to postpartum depression, according to a small study published in the Endocrine Society’s Journal of Clinical Endocrinology &… read more.

Community pharmacy input to Vac4covid

Written by | 8 Apr 2021

Interview and article by Christine Clark. Community pharmacies are at the heart of their communities and can contribute to the Vac4covid study by signposting patients to the website,… read more.

CHMP recommends expanded approval for Saxenda in obesity – Novo Nordisk

Written by | 7 Apr 2021

Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda (liraglutide) is… read more.

Where we live can affect male reproductive health

Written by | 7 Apr 2021

New research, led by scientists at the University of Nottingham, suggests that the environment in which men live may affect their reproductive health. The research, published in Scientific Reports,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.